- Home
- IMRN vs MCVT Comparison
IMRN vs MCVT Comparison
Compare IMRN & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MCVT
- Stock Information
- Founded
- IMRN 1994
- MCVT 2007
- Country
- IMRN Australia
- MCVT United States
- Employees
- IMRN N/A
- MCVT N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MCVT Finance Companies
- Sector
- IMRN Health Care
- MCVT Finance
- Exchange
- IMRN Nasdaq
- MCVT Nasdaq
- Market Cap
- IMRN 15.0M
- MCVT 14.7M
- IPO Year
- IMRN N/A
- MCVT N/A
- Fundamental
- Price
- IMRN $2.37
- MCVT $1.99
- Analyst Decision
- IMRN Strong Buy
- MCVT
- Analyst Count
- IMRN 1
- MCVT 0
- Target Price
- IMRN $5.00
- MCVT N/A
- AVG Volume (30 Days)
- IMRN 6.5K
- MCVT 135.5K
- Earning Date
- IMRN 10-22-2024
- MCVT 11-15-2024
- Dividend Yield
- IMRN N/A
- MCVT N/A
- EPS Growth
- IMRN N/A
- MCVT N/A
- EPS
- IMRN N/A
- MCVT 0.04
- Revenue
- IMRN $3,271,194.00
- MCVT $3,248,401.00
- Revenue This Year
- IMRN N/A
- MCVT N/A
- Revenue Next Year
- IMRN N/A
- MCVT N/A
- P/E Ratio
- IMRN N/A
- MCVT $53.85
- Revenue Growth
- IMRN 171.67
- MCVT N/A
- 52 Week Low
- IMRN $1.48
- MCVT $1.90
- 52 Week High
- IMRN $5.96
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- IMRN 36.85
- MCVT 35.52
- Support Level
- IMRN $2.21
- MCVT $1.90
- Resistance Level
- IMRN $2.87
- MCVT $2.20
- Average True Range (ATR)
- IMRN 0.13
- MCVT 0.26
- MACD
- IMRN -0.04
- MCVT -0.08
- Stochastic Oscillator
- IMRN 25.11
- MCVT 8.14
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.